CTS-1027

CAS: 193022-04-7

Ref. 3D-THA02204

Información del producto

• Nombre: CTS-1027
• Marca: Biosynth
• Descripción: CTS-1027 is a metalloprotease inhibitor that blocks the activity of matrix metalloprotease. CTS-1027 has been shown to inhibit HIV and also prevents tumor growth in mice. In vitro assays have shown that CTS-1027 inhibits the production of matrix metalloproteinase, which is associated with collagen degradation. The mechanism by which CTS-1027 inhibits matrix metalloproteinase is not known. This drug also has neuropathological effects, including the reduction of amyloid beta peptides in a mouse model of Alzheimer's disease. It also reduces the amount of amyloid beta peptides in a mouse model of Parkinson's disease and reduces the number of pathological cardiac cells in vivo models. Solid-phase synthesis was used to produce this compound at high purity levels.

Propiedades químicas

• Peso molecular: 425.88 g/mol
• Fórmula: C₁₉H₂₀ClNO₆S
• Pureza: Min. 95%